Qantas Labs Private Limited
About Qantas Labs Private Limited
Data last updated:
Qantas Labs Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24239CH2020PTC043400.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Satwant Singh and Ajay.
Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Sunil Kumar SCO 1009 Motor Market Commercial Complex Manimajra, Chandigarh, India – 160101.
Company details
Contact details
Qantas Labs Private Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O Sunil Kumar SCO 1009 Motor Market Commercial Complex Manimajra, Chandigarh, India – 160101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Qantas Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Qantas Labs Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Qantas Labs Private Limited, buy the company report.
Board of directors of Qantas Labs Private Limited
Qantas Labs has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satwant Singh Also directs: Grapple Lifesciences Private Limited, Ampira Biotechnics Private Limited, Medlex Biotechnics Private Limited and 1 more | Director | 16 Dec 2020 | 5 Years 10 Months | Current |
| Ajay Also directs: Grapple Lifesciences Private Limited, Ampira Biotechnics Private Limited, Medlex Biotechnics Private Limited and 1 more | Director | 16 Dec 2020 | 5 Years 10 Months | Current |
Auditor
Qantas Labs Private Limited is audited by VIKAS SANJIV & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIKAS SANJIV & ASSOCIATES | FY 2023 | 018361N |
Shareholding
The shareholding of Qantas Labs Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Qantas Labs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Qantas Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Qantas Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Qantas Labs Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
GST
No GST registration is on our record for Qantas Labs Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Qantas Labs Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Ajay was appointed as Director on 16 Dec 2020.
Frequently asked questions
Qantas Labs is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 December 2020 (6+ years old) and is registered under CIN U24239CH2020PTC043400.
Qantas Labs has 2 current directors:
- Satwant Singh - Director
- Ajay - Director
The latest financial statements of Qantas Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Qantas Labs is U24239CH2020PTC043400. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Qantas Labs was incorporated on 16 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chandigarh.
Ajay was appointed as Director on 16 Dec 2020. Satwant Singh was appointed as Director on 16 Dec 2020.
The registered office of Qantas Labs is at CO Sunil Kumar SCO 1009 Motor Market Commercial Complex Manimajra, Chandigarh, India – 160101.
Qantas Labs operates in the pharma industry, in the drug formulation and development segment.
Qantas Labs can be reached at its registered office: CO Sunil Kumar SCO 1009 Motor Market Commercial Complex Manimajra, Chandigarh, India – 160101.
Qantas Labs is registered under the jurisdiction of the Registrar of Companies (ROC), Chandigarh.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
